Researchers turn cancer resistance mutations into targets for new immunotherapies
by Weizmann Institute of Science edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant cells acquire mutations that enable them to survive […]
Researchers turn cancer resistance mutations into targets for new immunotherapies Read More »
